India names team to fix alleged regulatory lapses
This article was originally published in Scrip
Executive Summary
Swinging into damage-control mode following a damning parliamentary committee report on regulatory lapses in approving new drugs, India said that it had constituted a three member committee to suggest measures for systemic and other improvements at the Central Drugs Standard Control Organisation (CDSCO).